$Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care$

Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care

Abstract Background aims A phase II clinical trial of an autologous dendritic cell (DC) formulation for the management of refractory solid malignant tumors was conducted across six sites in India with an objective to study safety and efficacy. Methods A total of 51 patients with refractory cancer (e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cytotherapy (Oxford, England) England), 2014-02, Vol.16 (2), p.234-244
Hauptverfasser:	Bapsy, Poonamalle Parthasarathy, Sharan, Bandana, Kumar, Chaitanya, Das, Rajeev Patrick, Rangarajan, Bharath, Jain, Minish, Suresh Attili, Venkata Sathya, Subramanian, Sundaram, Aggarwal, Shyam, Srivastava, Mala, Vaid, Ashok
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Advanced Basic Science Aged Antigens, CD - metabolism Antigens, Neoplasm - immunology Antigens, Neoplasm - metabolism cancer immunotherapy Cancer Vaccines Carcinoma - immunology Carcinoma - mortality Carcinoma - therapy Cell Differentiation Cell Extracts - immunology Cells, Cultured Colonic Neoplasms - immunology Colonic Neoplasms - mortality Colonic Neoplasms - therapy Cytokines - immunology dendritic cells Dendritic Cells - immunology Dendritic Cells - transplantation Drug Resistance, Neoplasm Female Follow-Up Studies Head and Neck Neoplasms - immunology Head and Neck Neoplasms - mortality Head and Neck Neoplasms - therapy Humans Immunotherapy - methods India Male Middle Aged monocytes Other Ovarian Neoplasms - immunology Ovarian Neoplasms - mortality Ovarian Neoplasms - therapy Recurrence Survival Analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!